EBioMedicine

The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.

Publisher
Elsevier
Website
http://www.ebiomedicine.com/

Some content fromWikipedia, licensed underCC BY-SA

Oncology & Cancer

AI could help doctors diagnose lung cancer

Artificial intelligence (AI) could help doctors diagnose lung cancer earlier, according to a study led by researchers from The Royal Marsden NHS Foundation Trust in collaboration with The Institute of Cancer Research, London, ...